María del Carmen
Herrero Sánchez
Investigadora en el periodo 2011-2016
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (5)
2018
-
Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients
Infection and Immunity, Vol. 86, Núm. 12
2016
-
Effect of mTORC1/mTORC2 inhibition on T cell function: Potential role in graft-versus-host disease control
British Journal of Haematology, Vol. 173, Núm. 5, pp. 754-768
-
Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development
Journal of Hematology and Oncology, Vol. 9, Núm. 1
2015
-
Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms
Immunologic Research, Vol. 62, Núm. 2, pp. 175-188
2012
-
Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment
Leukemia Research, Vol. 36, Núm. 7, pp. 895-899